{"brief_title": "Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)", "brief_summary": "The purpose of this study is to evaluate improved results of treatment for patients entering an emergency department with asthma attacks when given an investigational IV administration of an approved drug (MK-0476, montelukast sodium) in addition to approved standard treatment.", "condition": ["Asthma"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["montelukast sodium", "placebo"], "description": ["Duration of Treatment: 1 dose", "Duration of Treatment: 1 dose"], "arm_group_label": ["Montelukast 7 mg", "Placebo"], "other_name": ["MK-0476", "montelukast"], "criteria": "Inclusion Criteria: - Individuals with acute asthma Exclusion Criteria: - Women of child bearing age - History of Chronic Obstructive Pulmonary Disease (COPD)", "gender": "All", "minimum_age": "15 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Asthma", "Montelukast"], "id": "NCT00092989"}